{
    "nct_id": "NCT02991677",
    "official_title": "Exercise Effect on Chemotherapy-Induced Neuropathic Pain, Peripheral Nerve Fibers",
    "inclusion_criteria": "* Diagnosis with cancer, stage I-IV\n* History of treatment with oxaliplatin, docetaxel, or paclitaxel, either alone or in combination with other agents\n* Completion of chemotherapy > 6 months < 1 year\n* Ability to walk on a treadmill\n* Medical clearance from oncologist or primary care provider\n* Presence of CIPN per National Cancer Institute Common Toxicity Criteria grade 1-3 (0-no signs/symptoms, 1-minor loss of function, 2-increased symptoms not interfering with activities of daily living (ADLs), 3-severe symptoms interfering with ADL, 4-disabling, and 5 is death)\n* Score on Neuropathic Pain Scale >1\n* Age 21-70\nHealthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 70 Years",
    "exclusion_criteria": "* Denial of CIPN\n* Other motor/sensory neuropathy caused by other than chemotherapy (i.e.alcohol-related, autoimmune diseases, diabetes)\n* Coronary artery disease\n* History of >1 chemotherapy regimen\n* Musculoskeletal conditions which preclude participation in an exercise training program\n* Pregnancy\n* Regular exerciser, defined as >90 minutes per week of aerobic exercise and any resistive training",
    "miscellaneous_criteria": ""
}